Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized Vancomycin Dosing in NICU Patients
NCT06161870Phase 4Recruiting
- Sponsor
- Central South University
- Start
- Jan 2021
- Primary completion
- Dec 2024
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in Gram-positive bacterial infection, sponsored by Central South University. Started Jan 2021; status: recruiting.
02
Drugs
vancomycin
03
Conditions
Gram-positive bacterial infection
Beyond the preview
Go deeper on NCT06161870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06161870.